EBO Stock Overview
Engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
EBOS Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NZ$36.60 |
| 52 Week High | NZ$38.60 |
| 52 Week Low | NZ$31.02 |
| Beta | 0.25 |
| 1 Month Change | -1.67% |
| 3 Month Change | -1.75% |
| 1 Year Change | 2.69% |
| 3 Year Change | -8.68% |
| 5 Year Change | 54.11% |
| Change since IPO | 1,512.80% |
Recent News & Updates
The Returns At EBOS Group (NZSE:EBO) Aren't Growing
Nov 11
Shareholders May Be More Conservative With EBOS Group Limited's (NZSE:EBO) CEO Compensation For Now
Oct 16Is EBOS Group (NZSE:EBO) Using Too Much Debt?
Oct 11Recent updates
The Returns At EBOS Group (NZSE:EBO) Aren't Growing
Nov 11Shareholders May Be More Conservative With EBOS Group Limited's (NZSE:EBO) CEO Compensation For Now
Oct 16Is EBOS Group (NZSE:EBO) Using Too Much Debt?
Oct 11Do EBOS Group's (NZSE:EBO) Earnings Warrant Your Attention?
Sep 29An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 22% Undervalued
Sep 15Earnings Not Telling The Story For EBOS Group Limited (NZSE:EBO)
Jul 27Are Investors Undervaluing EBOS Group Limited (NZSE:EBO) By 29%?
Jun 11EBOS Group (NZSE:EBO) Is Reinvesting At Lower Rates Of Return
May 28EBOS Group (NZSE:EBO) Seems To Use Debt Quite Sensibly
Apr 25Some Confidence Is Lacking In EBOS Group Limited's (NZSE:EBO) P/E
Mar 21EBOS Group (NZSE:EBO) Will Pay A Dividend Of A$0.5951
Feb 24EBOS Group Limited (NZSE:EBO) Just Released Its Half-Year Earnings: Here's What Analysts Think
Feb 23Returns At EBOS Group (NZSE:EBO) Appear To Be Weighed Down
Jan 23EBOS Group Limited's (NZSE:EBO) Business Is Trailing The Market But Its Shares Aren't
Dec 18An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 20% Undervalued
Nov 02Here's What To Make Of EBOS Group's (NZSE:EBO) Decelerating Rates Of Return
Oct 17EBOS Group (NZSE:EBO) Has A Pretty Healthy Balance Sheet
Oct 02EBOS Group's (NZSE:EBO) Upcoming Dividend Will Be Larger Than Last Year's
Aug 28Estimating The Intrinsic Value Of EBOS Group Limited (NZSE:EBO)
Aug 02EBOS Group (NZSE:EBO) Is Reinvesting At Lower Rates Of Return
Jun 26Estimating The Intrinsic Value Of EBOS Group Limited (NZSE:EBO)
May 02Is EBOS Group (NZSE:EBO) Using Too Much Debt?
Apr 14EBOS Group (NZSE:EBO) Could Be Struggling To Allocate Capital
Mar 14EBOS Group (NZSE:EBO) Is Paying Out A Larger Dividend Than Last Year
Feb 26A Look At The Fair Value Of EBOS Group Limited (NZSE:EBO)
Jan 06EBOS Group (NZSE:EBO) Might Be Having Difficulty Using Its Capital Effectively
Nov 28Here's Why EBOS Group Limited's (NZSE:EBO) CEO Compensation Is The Least Of Shareholders' Concerns
Oct 21EBOS Group Limited (NZSE:EBO) Shares Could Be 37% Below Their Intrinsic Value Estimate
Oct 05Does EBOS Group (NZSE:EBO) Have A Healthy Balance Sheet?
Sep 13EBOS Group (NZSE:EBO) Will Pay A Larger Dividend Than Last Year At A$0.5116
Aug 26Slowing Rates Of Return At EBOS Group (NZSE:EBO) Leave Little Room For Excitement
Jun 24An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 30% Undervalued
May 10Return Trends At EBOS Group (NZSE:EBO) Aren't Appealing
Mar 17We Think That There Are Issues Underlying EBOS Group's (NZSE:EBO) Earnings
Feb 26EBOS Group (NZSE:EBO) Is Paying Out A Larger Dividend Than Last Year
Feb 18EBOS Group Limited's (NZSE:EBO) Intrinsic Value Is Potentially 41% Above Its Share Price
Jan 22Is EBOS Group (NZSE:EBO) Using Too Much Debt?
Dec 26EBOS Group (NZSE:EBO) Has Some Way To Go To Become A Multi-Bagger
Oct 31An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 23% Undervalued
Oct 18Is EBOS Group (NZSE:EBO) A Risky Investment?
Sep 19Here's Why I Think EBOS Group (NZSE:EBO) Might Deserve Your Attention Today
Aug 05A Look At The Fair Value Of EBOS Group Limited (NZSE:EBO)
Jul 13EBOS Group's (NZSE:EBO) Returns Have Hit A Wall
Jun 09Do EBOS Group's (NZSE:EBO) Earnings Warrant Your Attention?
May 01Here's Why EBOS Group (NZSE:EBO) Can Manage Its Debt Responsibly
Apr 08A Look At The Intrinsic Value Of EBOS Group Limited (NZSE:EBO)
Mar 27Is EBOS Group Limited's (NZSE:EBO) Recent Performance Tethered To Its Attractive Financial Prospects?
Mar 15Shareholder Returns
| EBO | NZ Healthcare | NZ Market | |
|---|---|---|---|
| 7D | -1.2% | -0.1% | 1.1% |
| 1Y | 2.7% | -0.07% | 6.1% |
Return vs Industry: EBO exceeded the NZ Healthcare industry which returned -0.1% over the past year.
Return vs Market: EBO underperformed the NZ Market which returned 6.1% over the past year.
Price Volatility
| EBO volatility | |
|---|---|
| EBO Average Weekly Movement | 3.1% |
| Healthcare Industry Average Movement | 5.0% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in NZ Market | 9.1% |
| 10% least volatile stocks in NZ Market | 3.1% |
Stable Share Price: EBO has not had significant price volatility in the past 3 months compared to the NZ market.
Volatility Over Time: EBO's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1922 | 4,557 | John Cullity | www.ebosgroup.com |
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services.
EBOS Group Limited Fundamentals Summary
| EBO fundamental statistics | |
|---|---|
| Market cap | NZ$7.13b |
| Earnings (TTM) | NZ$300.08m |
| Revenue (TTM) | NZ$14.57b |
23.7x
P/E Ratio0.5x
P/S RatioIs EBO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EBO income statement (TTM) | |
|---|---|
| Revenue | AU$13.19b |
| Cost of Revenue | AU$11.56b |
| Gross Profit | AU$1.63b |
| Other Expenses | AU$1.36b |
| Earnings | AU$271.55m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.39 |
| Gross Margin | 12.38% |
| Net Profit Margin | 2.06% |
| Debt/Equity Ratio | 51.1% |
How did EBO perform over the long term?
See historical performance and comparisonDividends
3.4%
Current Dividend Yield78%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 10:33 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
EBOS Group Limited is covered by 16 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Saul Hadassin | Barrenjoey Markets Pty Limited |
| Benjamin Brayshaw | Barrenjoey Markets Pty Limited |
| Lyanne Harrison | BofA Global Research |